Literature DB >> 29070876

Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.

Kai-C Sonntag1,2,3, Woo-In Ryu4,5,6, Kristopher M Amirault4,5,6, Ryan A Healy4,5,6, Arthur J Siegel7, Donna L McPhie4,6, Brent Forester4,8, Bruce M Cohen4,6.   

Abstract

Body-wide changes in bioenergetics, i.e., energy metabolism, occur in normal aging and disturbed bioenergetics may be an important contributing mechanism underlying late-onset Alzheimer's disease (LOAD). We investigated the bioenergetic profiles of fibroblasts from LOAD patients and healthy controls, as a function of age and disease. LOAD cells exhibited an impaired mitochondrial metabolic potential and an abnormal redox potential, associated with reduced nicotinamide adenine dinucleotide metabolism and altered citric acid cycle activity, but not with disease-specific changes in mitochondrial mass, production of reactive oxygen species, transmembrane instability, or DNA deletions. LOAD fibroblasts demonstrated a shift in energy production to glycolysis, despite an inability to increase glucose uptake in response to IGF-1. The increase of glycolysis and the abnormal mitochondrial metabolic potential in LOAD appeared to be inherent, as they were disease- and not age-specific. Our findings support the hypothesis that impairment in multiple interacting components of bioenergetic metabolism may be a key mechanism contributing to the risk and pathophysiology of LOAD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29070876      PMCID: PMC5656579          DOI: 10.1038/s41598-017-14420-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  51 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

Review 3.  Why therapies for Alzheimer's disease do not work: Do we have consensus over the path to follow?

Authors:  Zareen Amtul
Journal:  Ageing Res Rev       Date:  2015-09-12       Impact factor: 10.895

4.  Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes.

Authors:  B Ehrenberg; V Montana; M D Wei; J P Wuskell; L M Loew
Journal:  Biophys J       Date:  1988-05       Impact factor: 4.033

Review 5.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 6.  Role of astrocytic glycolytic metabolism in Alzheimer's disease pathogenesis.

Authors:  Wen Fu; Jack H Jhamandas
Journal:  Biogerontology       Date:  2014-08-09       Impact factor: 4.277

7.  Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.

Authors:  Hadi Kharrazi; Asad Vaisi-Raygani; Zohreh Rahimi; Haidar Tavilani; Mahdi Aminian; Tayebeh Pourmotabbed
Journal:  Clin Biochem       Date:  2008-05-15       Impact factor: 3.281

8.  Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons.

Authors:  Sofia Söllvander; Elisabeth Nikitidou; Robin Brolin; Linda Söderberg; Dag Sehlin; Lars Lannfelt; Anna Erlandsson
Journal:  Mol Neurodegener       Date:  2016-05-12       Impact factor: 14.195

9.  Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

Authors:  Eugenia Trushina; Tumpa Dutta; Xuan-Mai T Persson; Michelle M Mielke; Ronald C Petersen
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

Review 10.  Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders.

Authors:  Yazan S Batarseh; Quoc-Viet Duong; Youssef M Mousa; Sweilem B Al Rihani; Khaled Elfakhri; Amal Kaddoumi
Journal:  Int J Mol Sci       Date:  2016-03-04       Impact factor: 5.923

View more
  41 in total

Review 1.  Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.

Authors:  Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du
Journal:  Ageing Res Rev       Date:  2021-10-29       Impact factor: 10.895

2.  Inorganic Polyphosphate, Mitochondria, and Neurodegeneration.

Authors:  Pedro Urquiza; Maria E Solesio
Journal:  Prog Mol Subcell Biol       Date:  2022

3.  Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.

Authors:  Tarin A Europa; Melissa Nel; Maribanyana R Lebeko; Jeannine M Heckmann
Journal:  IBRO Neurosci Rep       Date:  2022-04-21

Review 4.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

5.  Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions.

Authors:  Fernanda Cardoso Teixeira; Jessié Martins Gutierres; Mayara Sandrielly Pereira Soares; Bruna da Siveira de Mattos; Luiza Spohr; Carlus Augustu Tavares do Couto; Natália Pontes Bona; Charles Elias Assmann; Vera Maria Morsch; Ivana Beatrice Mânica da Cruz; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Psychopharmacology (Berl)       Date:  2019-12-13       Impact factor: 4.530

Review 6.  Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Giusy Tassone; Arian Kola; Daniela Valensin; Cecilia Pozzi
Journal:  Life (Basel)       Date:  2021-04-24

7.  Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 mice.

Authors:  Elena Puris; Štěpán Kouřil; Lukáš Najdekr; Sanna Loppi; Paula Korhonen; Katja M Kanninen; Tarja Malm; Jari Koistinaho; David Friedecký; Mikko Gynther
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

8.  Deficits in Mitochondrial Spare Respiratory Capacity Contribute to the Neuropsychological Changes of Alzheimer's Disease.

Authors:  Simon M Bell; Matteo De Marco; Katy Barnes; Pamela J Shaw; Laura Ferraiuolo; Daniel J Blackburn; Heather Mortiboys; Annalena Venneri
Journal:  J Pers Med       Date:  2020-04-29

Review 9.  Appetite, Metabolism and Hormonal Regulation in Normal Ageing and Dementia.

Authors:  Artemissia-Phoebe Nifli
Journal:  Diseases       Date:  2018-07-20

Review 10.  Metabolism navigates neural cell fate in development, aging and neurodegeneration.

Authors:  Larissa Traxler; Jessica Lagerwall; Sophie Eichhorner; Davide Stefanoni; Angelo D'Alessandro; Jerome Mertens
Journal:  Dis Model Mech       Date:  2021-08-04       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.